At a glance: Milk thistle is the fruit of Silybum marianum (L.) Gaertn., an Asteraceae plant whose extracts contain the flavonolignan mixture known as silymarin. Milk thistle is heavily marketed for “liver detox” and liver protection, but high-quality human evidence does not justify such a sweeping claim. Clinical trials in liver disease have been inconsistent or too limited for firm conclusions, despite extensive laboratory and preclinical research.[1][2][3]
Botanical profile
- Accepted name: Silybum marianum (L.) Gaertn.
- Common names: milk thistle, Mary thistle.
- Family: Asteraceae.
- Medicinal part: fruit (often casually called the “seed”).
- EMA herbal drug name: Silybi mariani fructus.[1]
Milk thistle is a robust annual or biennial plant with glossy, white-marbled, spiny leaves and purple flower heads. The medicinal material is the mature fruit, botanically an achene-like cypsela rather than a true seed in the everyday sense.
Major constituent groups
The best-known preparation is silymarin, a mixture concentrated from the fruit. It contains several flavonolignans, including:
- silybin (silibinin) A and B, often the most abundant components;
- isosilybin A and B;
- silychristin and isosilychristin;
- silydianin; and
- related flavonoids such as taxifolin alongside fatty acids and other fruit constituents.[4][5]
“Milk thistle”, “silymarin” and “silibinin” are therefore not synonyms. Milk thistle fruit is the herbal drug; silymarin is a mixture extracted from it; silibinin is a major constituent or defined mixture within that fraction.
Traditional use
Milk thistle fruit has traditionally been used for liver and gallbladder complaints, sluggish digestion, jaundice and digestive discomfort associated with rich food or alcohol. European herbal traditions also used the plant as a bitter digestive tonic. The plant has additionally had a historical reputation as a galactagogue for supporting breast-milk production, reflected in the old name “milk thistle”.
Contemporary herbal practice
Contemporary herbalists commonly think of milk thistle as a hepatic restorative rather than as a generic “detox”. It is frequently used in longer-term formulations where liver stress, medication burden or impaired digestive tolerance is part of the clinical picture, often alongside herbs such as dandelion, artichoke or gentian according to the person. The distinction between whole fruit, silymarin extract and purified silibinin matters in practice as much as it does in research.
EMA regulatory assessment
The European Medicines Agency HMPC has an EU herbal monograph for Silybum marianum fruit within the gastrointestinal therapeutic area. The first final EU monograph was published in 2018, with an assessment-report addendum published in 2024 after a periodic-review data call.[1]
Students should use the monograph itself for the precise authorised traditional-use wording and preparation specifications. The existence of an EU herbal monograph does not mean that every commercial silymarin supplement has proven efficacy for chronic liver disease.
The “liver herb” reputation
Milk thistle has a long historical association with hepatobiliary complaints and is promoted commercially for hepatitis, fatty liver disease, alcohol-related liver injury and general “detoxification”. That marketing reputation is substantially broader than the clinical evidence.
NCCIH concludes that there is not enough high-quality evidence to draw definite conclusions about milk thistle for human health conditions. Trials in alcohol-related liver disease, hepatitis B and C, non-alcoholic fatty liver disease and other liver disorders have produced conflicting or insufficient results.[2]
Systematic-review evidence in liver disease
A systematic review and meta-analysis by Jacobs and colleagues found that available trials did not establish meaningful benefits on mortality, histology or liver-function outcomes and emphasised substantial limitations in the evidence base.[3]
A later pharmacological review likewise described extensive experimental evidence for antioxidant, anti-inflammatory, antifibrotic and other actions while concluding that better-designed randomised clinical trials were still required to establish the real clinical value of milk-thistle preparations in liver disease.[4]
What did larger modern trials find?
NCCIH highlights two federally funded trials in clinically important liver populations. A randomised trial of silymarin in people with chronic hepatitis C who had not responded to interferon did not demonstrate the hoped-for biochemical benefit, and a trial in non-alcoholic steatohepatitis likewise did not show a clear benefit from silymarin supplementation.[2]
This matters because positive laboratory findings cannot substitute for clinical outcomes in people with established liver disease.
Pharmacology
Silymarin and individual flavonolignans have been studied for antioxidant, anti-inflammatory, antifibrotic, membrane-stabilising and immunomodulatory effects. Experimental models also examine effects on oxidative stress, inflammatory signalling and fibrogenesis.[4][5]
These mechanisms are plausible reasons to conduct clinical trials; they are not proof that an over-the-counter milk-thistle capsule “detoxes the liver”.
Preparations and bioavailability
Products may contain powdered fruit, dry extracts standardised to silymarin, purified silymarin fractions or more specialised formulations designed to alter absorption. Silymarin has relatively poor and variable oral bioavailability, and formulations intended to improve absorption can alter pharmacokinetics.
Clinical findings should therefore be tied to the actual extract and formulation studied. A result generated with one standardised product cannot automatically be assigned to every bottle labelled “milk thistle”.
Product quality
Quality control is a genuine issue. NCCIH notes studies in which commercial milk-thistle supplements contained silymarin amounts that differed substantially from the label or showed contamination with pesticides, microorganisms or mycotoxins.[2]
For students, this is an important reminder that a clinical trial evaluates an intervention, not merely a plant name. Botanical identity, extraction, chemical specification and manufacturing quality are part of the intervention.
Safety
Oral milk thistle is generally well tolerated in available studies. Common adverse effects are gastrointestinal, including bloating, nausea and gas.[2]
Allergic reactions are possible, particularly in people sensitive to other Asteraceae such as ragweed, chrysanthemums, marigolds and daisies.
Interactions
Laboratory and pharmacokinetic interaction concerns have been investigated, but the clinical relevance varies by medicine and preparation. People taking prescription medicines should not assume that “liver support” products are interaction-free simply because the evidence for clinical benefit is uncertain.
Pregnancy and breastfeeding
Human safety data in pregnancy and breastfeeding are limited. Historical claims that milk thistle increases breast-milk production have not been established by reliable clinical evidence.[2]
Student note: common evidence traps
- Do not use “milk thistle”, “silymarin” and “silibinin” interchangeably.
- Do not convert antioxidant activity into a clinical “detox” claim.
- Abnormal liver enzymes are surrogate outcomes; they are not automatically equivalent to improved survival, fibrosis or symptoms.
- Record extract standardisation and formulation when comparing trials.
- Do not treat an EMA monograph as proof that commercial supplements treat chronic liver disease.
- Commercial product quality may differ markedly from research-grade preparations.
References
- European Medicines Agency, Committee on Herbal Medicinal Products. Silybi mariani fructus — Silybum marianum (L.) Gaertn., fructus. EU herbal monograph, assessment report and 2024 addendum. EMA. Final monograph published 2018.
- National Center for Complementary and Integrative Health. Milk Thistle: Usefulness and Safety. NCCIH. Updated February 2025; consulted September 2026.
- Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence VA. Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. American Journal of Medicine. 2002;113(6):506–515. doi:10.1016/S0002-9343(02)01244-5. PubMed.
- Abenavoli L, Izzo AA, Milić N, Cicala C, Santini A, Capasso R. Milk thistle (Silybum marianum): a concise overview of its chemistry, pharmacological and nutraceutical uses in liver diseases. Phytotherapy Research. 2018;32(11):2202–2213. doi:10.1002/ptr.6171. PubMed.
- Recent review of the botany, phytochemistry and pharmacology of Silybum marianum, including flavonolignan composition. 2024. PubMed.
Additional materia medica sources
- ESCOP. Silybi mariani fructus — Milk thistle fruit, ESCOP Monographs.
- Blumenthal M, et al., eds. The Complete German Commission E Monographs. American Botanical Council; 1998.
- Mills S, Bone K. Principles and Practice of Phytotherapy. 2nd ed. Elsevier; 2013.
- Hoffmann D. Medical Herbalism. Healing Arts Press; 2003.
Last reviewed: 20 September 2026. Educational reference only; not an individual dosing or prescribing guide.
← Return to the Herbal Monograph Library | Herbal Medicine Safety and Interactions